Horton hears a promotion at Nile
This article was originally published in Scrip
Executive Summary
Dr Darlene Horton, who was recently appointed CMO at Nile Therapeutics (scripintelligence.com, 2 July 2012), has been promoted to president and CEO and a director of the company. Dr Horton previously served as CMO at Itero, a company she co-founded. Joshua Kazam, who has served as Nile's president and CEO on a part-time basis since June 2009, agreed to resign upon Dr Horton's appointment. He will continue to serve on the company's board of directors.